mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |